Cafepharma Today

May 28 2025 - GLP-1 prescriptions for weight loss soar, despite obstacles
GLP-1 prescriptions for weight loss soar, despite obstacles
FDA approves use of Sanofi's meningococcal vaccine in infants
GSK's $66M bet on Spero's rejected UTI antibiotic pays off with a phase 3 win
AbbVie's Allergan Aesthetics unit plots 202 layoffs after recent sales slide
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Crunching the Data: Seven Big Pharmas With Consistent Dividends
Seeking Alpha
Saturday, April 23, 2011 - 10:50am
tags:
Bristol-Myers Squibb, Abbott Laboratories, JNJ, AstraZeneca, Eli Lilly, Merck
Vanda Pharmaceuticals to Announce First Quarter 2011 Financial Results on May 5, 2011
Yahoo/PR NewsWire
Saturday, April 23, 2011 - 10:48am
tags:
Vanda, earnings
Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Yahoo/BusinessWire
Saturday, April 23, 2011 - 10:47am
tags:
Idera Pharmaceuticals, IMO-2125, HCV, toll-like Receptor (TLR) 9 agonist
BioCryst to Present New BCX4208 Gout Results at the Annual European Congress of Rheumatology
Yahoo/BusinessWire
Saturday, April 23, 2011 - 10:46am
tags:
gout, Biocryst, BCX4208, purine nucleoside phosphorylase inhibitor
Biogen surges on data for MS oral drug candidate
Yahoo/AP
Friday, April 22, 2011 - 8:34am
tags:
MS, multiple sclerosis, Biogen Idec, BG-12
Merck's Risky Bet on Research
Businessweek
Friday, April 22, 2011 - 7:56am
tags:
Merck, R&D
Crunching the Data: Seven Big Pharmas With Consistent Dividends
Seeking Alpha
Friday, April 22, 2011 - 7:54am
tags:
dividends, Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, JNJ, Eli Lilly, Merck, Novartis
Nektar ovarian cancer drug gets FDA orphan status
Bizjournals.com
Thursday, April 21, 2011 - 6:53pm
tags:
orphan drugs, ovarian cancer, FDA, Nektar, NKTR-102
Teva: Fallen Angel Looking Up?
Seeking Alpha
Thursday, April 21, 2011 - 6:52pm
tags:
Teva Pharmaceuticals, Novartis
Pfizer Falls After Four Deaths Occur in Study of Arthritis Drug
Bloomberg
Thursday, April 21, 2011 - 6:50pm
tags:
rheumatoid arthritis, Pfizer, tofacitinib
Bristol-Myers Earnings Preview
Yahoo/Zacks.com
Thursday, April 21, 2011 - 6:48pm
tags:
Bristol-Myers Squibb, earnings
Report: GSK mulls deal for India vaccines unit
Fierce Pharma
Thursday, April 21, 2011 - 11:49am
tags:
vaccines, GSK, M&A, Biological E, India
Incyte and YM Biosciences in Race to Market Strongest JAK Inhibitor
Seeking Alpha
Thursday, April 21, 2011 - 11:46am
tags:
JAK inhibitors, YM BioSciences, Incyte, myelofibrosis
AEterna Zentaris Looks Ready to Make New Highs
Seeking Alpha
Thursday, April 21, 2011 - 11:01am
tags:
Aeterna Zentaris, perifosine
Amgen says it will pay dividend starting in 2Q
Yahoo/AP
Thursday, April 21, 2011 - 10:56am
tags:
dividends, Amgen
How Do These Pharmas Really Boost Their Returns?
Motley Fool
Thursday, April 21, 2011 - 10:56am
tags:
Merck, Pfizer, Abbott Laboratories, GSK, ROE
Should You Sell Abbott Labs Today?
Motley Fool
Thursday, April 21, 2011 - 10:37am
tags:
Abbott Laboratories
Titan Should Be on the Biotech Watch Lists Right Now
Seeking Alpha
Thursday, April 21, 2011 - 9:54am
tags:
Titan, Novartis, Fanapt
Biogen revenue, profit up in Q1
Bizjournals.com
Thursday, April 21, 2011 - 9:50am
tags:
Biogen Idec, earnings
Depomed: Light-Risk Small Pharma With Huge Potential
Seeking Alpha
Thursday, April 21, 2011 - 9:49am
tags:
Depomed

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.